1. Home
  2. TYRA vs TNC Comparison

TYRA vs TNC Comparison

Compare TYRA & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$25.23

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$66.61

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
TNC
Founded
2018
1870
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
TYRA
TNC
Price
$25.23
$66.61
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$47.50
$79.00
AVG Volume (30 Days)
1.0M
156.6K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
1.53%
EPS Growth
N/A
N/A
EPS
N/A
0.45
Revenue
N/A
$1,137,600,000.00
Revenue This Year
N/A
$5.77
Revenue Next Year
N/A
$4.95
P/E Ratio
N/A
$148.02
Revenue Growth
N/A
N/A
52 Week Low
$12.38
$60.18
52 Week High
$40.65
$91.93

Technical Indicators

Market Signals
Indicator
TYRA
TNC
Relative Strength Index (RSI) 48.74 34.81
Support Level $24.58 $64.88
Resistance Level $27.02 $88.96
Average True Range (ATR) 2.07 2.20
MACD 0.16 0.09
Stochastic Oscillator 61.06 9.62

Price Performance

Historical Comparison
TYRA
TNC

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About TNC Tennant Company

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.

Share on Social Networks: